Top Markets
#1 Smilek to the Bank Smilek to the Bank +50.56%
#2 Purr Purr +47.43%
#3 Pons Pons +45.47%
#4 Non-Playable Coin Non-Playable Coin +27.80%
#5 StonkBroker StonkBroker +27.01%
#6 ApeX ApeX +25.69%
#7 Kinetiq Kinetiq +25.58%
#8 Pudgy Penguins Pudgy Penguins +21.53%
#9 OriginTrail OriginTrail +19.79%
#10 Grass Grass +19.50%
Coin of the day
Smilek to the Bank Smilek to the Bank
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
CANbridge Pharmaceuticals Inc. CANbridge Pharmaceuticals Inc.

CANbridge Pharmaceuticals Inc.

1228
Kedudukan dalam Saham #21196
CANbridge Pharmaceuticals Inc. is a biopharmaceutical company focused on the... CANbridge Pharmaceuticals Inc. is a biopharmaceutical company focused on the global research, development, and commercialization of treatments for rare disorders and various cancer types. The company's marketed products include Hunterase, an enzyme replacement therapy for Hunter syndrome; NERLYNX (Neratinlib), a powerful, irreversible tyrosine kinase inhibitor targeting HER2-positive breast cancer; and Caphosol Mouth Rinse, used to alleviate temporary and persistent dry mouth and throat. Its robust development pipeline features several investigational therapies: CAN008, an artificially engineered antibody-like fully human fusion protein being developed for glioblastoma multiforme; CAN108, an orally administered reversible inhibitor of the ileal bile acid transporter, designed to treat rare cholestatic liver diseases; CAN106, a humanized monoclonal antibody against complement C5 for complement-mediated conditions; CAN103 and CAN104, both recombinant human enzyme replacement therapies (ERTs); CAN105, a bispecific antibody; and gene therapy programs CAN201 and CAN202, both utilizing adeno-associated virus (AAV) sL65 capsid technology. Established in 2012, CANbridge Pharmaceuticals Inc. is based in Beijing, China.
Harga Saham
$0.26544693
Disegerakkan terakhir: 2026-08-21
Modal Pasaran
$112.77M
Perubahan (1 hari)
-0.72%
Perubahan (1 tahun)
-16.36%
Negara
CN
Perdagangan CANbridge Pharmaceuticals Inc. (1228)

Kategori

Healthcare
Sejarah dividen untuk CANbridge Pharmaceuticals Inc. (1228)
CANbridge Pharmaceuticals Inc. (simbol saham: 1228) telah membuat sejumlah 0 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): 0.00
Hasil dividen (TTM): 0
Pembayaran dividen untuk CANbridge Pharmaceuticals Inc. (1228) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (diselaraskan untuk pemecahan saham) Ubah
Tidak cukup data untuk tarikh yang disediakan.
Senarai semua pembayaran dividen
Tahun Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pembayaran dividen untuk syarikat serupa atau pesaing
Syarikat Jumlah pembayaran dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH